Vaccination against the Epstein-Barr virus
Epstein–Barr virus (EBV) was the first human tumor virus being discovered and remains to date the only human pathogen that can transform cells in vitro. 55 years of EBV research have now brought us to the brink of an EBV vaccine. For this purpose, recombinant viral vectors and their heterologous pri...
Những tác giả chính: | Rühl, J, Leung, CS, Münz, C |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Springer Nature
2020
|
Những quyển sách tương tự
-
Redirecting T Cells against Epstein–Barr Virus Infection and Associated Oncogenesis
Bằng: Christian Münz
Được phát hành: (2020-06-01) -
Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
Bằng: Christian Münz
Được phát hành: (2017-11-01) -
Immune Escape by Non-coding RNAs of the Epstein Barr Virus
Bằng: Christian Münz
Được phát hành: (2021-06-01) -
Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection
Bằng: Christian Münz
Được phát hành: (2021-12-01) -
Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
Bằng: Wesley I. Soo Hoo, et al.
Được phát hành: (2023-07-01)